CRBP

CRBP

USD

Corbus Pharmaceuticals Holdings Inc. Common Stock

$11.250-0.880 (-7.255%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$12.130

Hoch

$12.168

Tief

$11.230

Volumen

0.56M

Unternehmensfundamentaldaten

Marktkapitalisierung

191.2M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.27M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $4.64Aktuell $11.250Hoch $20.77

Ähnliche Nachrichten

GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public

Mehr anzeigen
Corbus Pharmaceuticals Announces Pricing of Public Offering
GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced that it plans to offer and sell shares

Mehr anzeigen
Corbus Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025

Mehr anzeigen
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025